Benchling
Benchling makes an AI platform for biotech R&D that helps scientists design experiments, capture structured data, and run AI agents and models in their workflows.
Benchling builds an AI platform for biotech R&D. Its software helps scientists design experiments, capture structured data, and run AI agents and models directly within their workflows, unifying scientific data and automating processes across the research lifecycle. The Benchling Platform is used by more than 200,000 scientists worldwide, and more than half of the top 50 biopharma companies work with the company; customers include Sanofi and Moderna.
The company's technical work spans AI agents and models, experiment design, structured scientific data capture, workflow automation, bioinformatics and R&D software, and CRISPR gene engineering tools. It serves customers in biopharma, agriculture, materials, cell therapies, cultivated meat and academic research labs, with a geographic presence described as worldwide.
Benchling was founded by former academic researchers, and nearly half of its team comes from R&D backgrounds. The company describes its mission as accelerating scientific discovery, with an emphasis on understanding scientists' needs and turning experiments into results. Further details are available at https://benchling.com/.
